These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24808662)

  • 21. Micro-suspension coating method: a new approach in formulation and development of controlled porosity osmotic pump systems.
    Adibkia K; Hanaee J; Ghanbarzadeh S; Bahrami R; Shokri J
    Drug Res (Stuttg); 2014 Apr; 64(4):203-7. PubMed ID: 24026954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology.
    Verma RK; Kaushal AM; Garg S
    Int J Pharm; 2003 Sep; 263(1-2):9-24. PubMed ID: 12954176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production and
    Ma C; Huang Z; Zhu Y; Chen X; Singh V; Huang Y; Pan X; Wu C
    Pharmazie; 2017 Sep; 72(9):511-517. PubMed ID: 29441977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled porosity osmotic pump system with biphasic release of theophylline.
    Bi Y; Mao S; Gan L; Li Y; Wang C; Xu N; Zheng Y; Cheng Q; Hou S
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1574-80. PubMed ID: 17978514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and in vitro/in vivo evaluation of etodolac controlled porosity osmotic pump tablets.
    Abd-Elbary A; Tadros MI; Alaa-Eldin AA
    AAPS PharmSciTech; 2011 Jun; 12(2):485-95. PubMed ID: 21479749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microporous bilayer osmotic tablet for colon-specific delivery.
    Chaudhary A; Tiwari N; Jain V; Singh R
    Eur J Pharm Biopharm; 2011 May; 78(1):134-40. PubMed ID: 21255646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled porosity osmotic pump for the delivery of flurbiprofen.
    Chauhan CS; Choudhury PK
    Curr Drug Deliv; 2006 Apr; 3(2):193-8. PubMed ID: 16611005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization.
    Prabakaran D; Singh P; Kanaujia P; Jaganathan KS; Rawat A; Vyas SP
    Int J Pharm; 2004 Oct; 284(1-2):95-108. PubMed ID: 15454301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro.
    Fu HX; Li H; Zhang FZ; Zhao YZ; Wan CW; Chen MT; Jia XC; Yan L; Sun CC; Xu YY
    Drug Dev Ind Pharm; 2012 Jun; 38(6):670-8. PubMed ID: 22469006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent patent in controlled porosity osmotic pump.
    Patel A; Mehta T; Patel M; Patel K; Patel N
    Recent Pat Drug Deliv Formul; 2013 Apr; 7(1):66-72. PubMed ID: 22934628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Situ Phase-Transited Asymmetric Membrane Capsules: A Means for Achieving Delayed and Osmotic Release for pH Solubility-Dependant Drugs.
    Philip AK; Philip B
    PDA J Pharm Sci Technol; 2011; 65(1):32-41. PubMed ID: 21414938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel controlled porosity osmotic pump system for sodium ferulate.
    He L; Gong T; Zhao D; Zhang ZR; Li L
    Pharmazie; 2006 Dec; 61(12):1022-7. PubMed ID: 17283661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained release formulation of Ondansetron HCl using osmotic drug delivery approach.
    Gundu R; Pekamwar S; Shelke S; Shep S; Kulkarni D
    Drug Dev Ind Pharm; 2020 Mar; 46(3):343-355. PubMed ID: 31937128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and optimization of micro/nanoporous osmotic pump tablets.
    Tuntikulwattana S; Mitrevej A; Kerdcharoen T; Williams DB; Sinchaipanid N
    AAPS PharmSciTech; 2010 Jun; 11(2):924-35. PubMed ID: 20499218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and in vitro/in vivo evaluation of vinpocetine elementary osmotic pump system.
    Ning M; Zhou Y; Chen G; Mei X
    Adv Pharmacol Sci; 2011; 2011():385469. PubMed ID: 21577257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Push-pull osmotic pump for zero order delivery of lithium carbonate: development and in vitro characterization.
    Patel V; Chudasama A; Nivsarkar M; Vasu K; Shishoo C
    Pharm Dev Technol; 2012; 17(3):375-82. PubMed ID: 21284541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastroretentive drug delivery system of Ranitidine hydrochloride based on osmotic technology: development and evaluation.
    Kumar P; Singh S; Mishra B
    Curr Drug Deliv; 2008 Oct; 5(4):332-42. PubMed ID: 18855605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of a 24-hour controlled porosity osmotic pump system containing PVP: formulation variables.
    Yakubu R; Peh KK; Tan YT
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1430-8. PubMed ID: 19929202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs.
    Shokri J; Ahmadi P; Rashidi P; Shahsavari M; Rajabi-Siahboomi A; Nokhodchi A
    Eur J Pharm Biopharm; 2008 Feb; 68(2):289-97. PubMed ID: 17616378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.